CBIO Q3 2019 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$337M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$70,783

Operating Income

-$14M

Net Income

-$13M

EPS (Diluted)

$-0.31

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$180M

Total Liabilities

$13M

Stockholders' Equity

$167M

Cash & Equivalents

$171M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$70,783	-$68,477	-3.4%
Operating Income	-$14M	-$13M	-12.7%
Net Income	-$13M	-$12M	-14.5%